These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 164781)

  • 1. Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders.
    Dellon AL; Ptovin C; Chretien PB
    Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):500-11. PubMed ID: 164781
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment.
    Dellon AL; Potvin C; Chretien PB
    Cancer; 1975 Mar; 35(3):687-94. PubMed ID: 163138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of human monocyte Fc receptors in malignant disease.
    Rhodes J
    Nature; 1977 Jan; 265(5591):253-5. PubMed ID: 189209
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the lung: an evaluation of the scalene node biopsy in relation to radiation therapy of the supraclavicular region.
    Huber CM; DeGiorgi LS; Levitt SH; King ER
    Cancer; 1972 Jan; 29(1):84-9. PubMed ID: 4332319
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression and reconstitution with thymosin after radiation therapy.
    Wara WM; Wara DW; Ammann AJ; Barnard JL; Phillips TL
    Int J Radiat Oncol Biol Phys; 1979 Jul; 5(7):997-1001. PubMed ID: 511632
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocompetence of patients with bronchogenic carcinoma.
    Olkowski ZL; McLaren JR; Mansour KA
    Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation therapy of brain tumors metastatic from bronchogenic carcinoma].
    Sasai K; Ono K; Hiraoka M; Tsutsui K; Takahashi M; Abe M; Hamakawa J; Nadai C
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 May; 48(5):602-7. PubMed ID: 2842727
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of supraclavicular area treatment in radiotherapeutic management of lung cancer.
    Emami B; Lee DJ; Munzenrider JE
    Cancer; 1978 Jan; 41(1):124-9. PubMed ID: 203376
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation therapy for cancer of the lung: previous experience and definition of current issues.
    Perez CA
    Cancer Chemother Rep 3; 1973 Mar; 4(2):145-52. PubMed ID: 4354039
    [No Abstract]   [Full Text] [Related]  

  • 12. Radical radiation therapy for cancer of the lung.
    Fingerhut AG; Chin FK; Shultz EH
    Chest; 1971 Sep; 60(3):244-5. PubMed ID: 4999193
    [No Abstract]   [Full Text] [Related]  

  • 13. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma.
    Choi NC; Grillo HC; Gardiello M; Scannell JG; Wilkins EW
    Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):31-5. PubMed ID: 6767662
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic status in lung cancer.
    Brugarolas A; Takita H
    Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison between neutron and telecobalt therapy of bronchial, stomach and esophageal carcinoma].
    Eichhorn HJ; Lessel A; Matschke S
    Strahlentherapie; 1974 Jun; 147(6):559-63. PubMed ID: 4373876
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach.
    Choi NC; Doucette JA
    Cancer; 1981 Jul; 48(1):101-9. PubMed ID: 6263449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure in patients with inoperable carcinoma of the lung.
    Stanley K; Cox JD; Petrovich Z; Paig C
    Cancer; 1981 Jun; 47(11):2725-9. PubMed ID: 6266640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immune status of patients with bronchial cancer].
    Aulenbacher P; Manke HG; Drings P
    Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 20. [The superior vena cava syndrome as an emergency in radiotherapy].
    Beck C; Berberich W; Bauknecht A; Schnabel K
    Strahlenther Onkol; 1990 Dec; 166(12):798-802. PubMed ID: 2176355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.